News Article | May 8, 2017
More than 1,200 national and international surgeons, anesthesiologists and their teams have come to UAB to learn his techniques and the way in which he engages his teams to provide efficient, high-quality and patient-centered care. During his tenure at UAB, he developed a four-arm robotic approach to treat patients needing lung cancer excisions, removal of cancerous esophageal tumors and tumor resections within the thoracic region. His robotic techniques have reduced complications, increased survival and shortened hospital stays. In addition to his position at UAB, Cerfolio serves as the director of the American Association of Thoracic Surgery's Robotic Graham Fellowship, and has trained a large percentage of thoracic surgeons in the U.S. and abroad. "We are excited to welcome Dr. Cerfolio to lead our Clinical Thoracic Surgery Division," said Aubrey C. Galloway, MD, the Seymour Cohn Professor and chair of the Department of Cardiothoracic Surgery. "He has a proven track record of exceptional patient outcomes, and will strengthen our robust thoracic surgery and lung cancer programs with his extraordinary expertise in robotic thoracic surgery." According to the U.S. Centers for Disease Control and Prevention, more Americans die from lung cancer than any other type of cancer – approximately 155,000 annually. In 2013, the most recent year for statistics, more than 212,500 individuals were diagnosed with lung cancer – almost equally divided between men and women. At Perlmutter Cancer Center, Cerfolio will lead a new multidisciplinary lung cancer center, bolstered by nationally renowned surgeons, medical and radiation oncologists, radiologists, pulmonologists and other specialists. Some have long tenure at NYU Langone and others are newly-recruited clinical and investigative leaders – all committed to developing a program that rivals the very best in the country. "Lung cancer is an insidious disease that is difficult to treat, especially when it progresses to more advanced stages," said Benjamin G. Neel, MD, PhD, director of NYU Langone's Perlmutter Cancer Center. "Dr. Cerfolio will provide a new level of excellence to our rapidly expanding lung cancer program. Patients who turn to us can rest assured they will have access to the finest clinical care, the latest treatments and the most advanced cutting-edge research." Cerfolio earned both his undergraduate and medical degrees from the University of Rochester where he was a First Team Academic All-American baseball player and a Rhodes Scholar Candidate. He received his first two years of post-doctoral surgical training at The University of Connecticut St. Francis Hospital. After a year of urologic surgical training at Cornell and Memorial Sloan Kettering, he completed the last two years of his general surgical residency at the Mayo Clinic in Rochester, Minnesota, where he also completed a cardiothoracic surgical fellowship. In 2013, he received his MBA from the University of Tennessee. He joined UAB in 1996, where he served in numerous academic and clinical positions before being named Division Chief in Thoracic Surgery in 2002. He also serves as the chair of UAB's Business Intelligence Committee. Cerfolio has published over 150 original peer-reviewed articles, 40 book chapters, and has given over 400 lectures and presentations at major international and national scientific meetings. He also has been an invited visiting professor at hundreds of major academic institutions in more than 22 countries. In 2014, he authored his first book, Super Performing at Work and at Home: The Athleticism of Surgery and Life, and has recently completed his second book on leadership entitled, Inspire. "I'm honored to join NYU Langone and its Perlmutter Cancer Center, and to be asked to be part of a team that brings together all elements of lung cancer care to provide the very best to our patients, many of whom are in the fight of their lives," Cerfolio says. "We plan for innovative ways to serve patients in the New York tri-state and those all over the world." This news release was issued on behalf of Newswise(TM). For more information, visit http://www.newswise.com. To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-lung-cancer-center-at-nyu-langone-welcomes-renowned-thoracic-surgeon-as-its-director-300452614.html
News Article | April 17, 2017
Covington, Louisiana – Lakeview Regional Medical Center has added nearly 20 former Louisiana Heart Hospital physicians and providers to its Lakeview Regional Physician Group, helping provide continuity of care to patients affected by the heart hospital’s recent closure. The providers join more than a dozen experienced physicians and other staff at Lakeview Regional Physician Group, a multi-specialty practice offering family medicine, cardiology, orthopedics, general surgery and internal medicine. Most will continue in the same former Louisiana Heart Hospital clinic locations – in Covington, Hammond, Lacombe and Slidell – to minimize patient disruption. “We are honored that these highly skilled and experienced physicians and nurse practitioners chose to join our team at Lakeview Regional,” said Bret Kolman, Lakeview Regional president and CEO. “They bring with them an invaluable wealth of knowledge, years of experience and the same compassion we share with our patients.” Lakeview Regional Physician Group welcomes the following former LHH medical staff: Farhad Aduli, MD (Interventional Cardiology), Sergio Barrios, MD (Interventional Cardiology), John Breaux, MD (Cardiothoracic Surgery), Cary Gray, MD (General Surgery), Adam Hankins, MD (Vascular Surgery), Sandra Hubbard, NP (Nurse Practitioner), David Kaplan, MD (Vascular Surgery), Jeffery Kitch, APRN (Nurse Practitioner), Barry Kusnick, MD (Interventional Cardiology), Christina McKinley, MD (Family Medicine), Anthony Morales, MD (Interventional Cardiology), Adriana Nagy, MD (Noninterventional Cardiology), Carol Raymond, CFNP (Nurse Practitioner), Darren Rowan, MD (General Surgery), Richard Sanders, MD (Family Medicine), Jay Silverstein, MD (Noninterventional Cardiology), Ulrich Starke, MD (Internal Medicine), Danielle Tranchina, APRN (Nurse Practitioner), Bassam Wanna, MD (Cardiac Electrophysiology). “Patients can expect continuity of care with the highest quality in medical treatment,” Kolman said. “With five locations, patients will find the convenience a benefit, as well as a broader range of services and an increased network of physicians.” For more information, please visit LakeviewPhysicianGroup.com. The five locations, and physicians at each, include: 20 Starbush Circle, Covington, LA (985)871-6020 Frahad Aduli, MD Adraina Nagy, MD Christina Leal-McKinley, MD Ulrich Starke, MD Darren Rowan, MD Bassam Wanna, MD Jeffery Kitch, APRN Conveniently located on the North shore of Lake Pontchartrain just south of I-12 on 190, Lakeview Regional Medical Center (LRMC) is a 167-bed, private, acute care hospital that has been delivering award-winning, cost effective healthcare for over 35 years. Lakeview Regional’s Emergency Department offers 24-hour care by a comprehensive, multi-disciplinary team of board certified physicians. The hospital’s 750 highly trained employees are dedicated to providing the highest quality patient care through state of the art technology. The hospital is located on 53 lush acres at 95 Judge Tanner Blvd., Covington, Louisiana 70433. For more information about LRMC, please visit http://www.lakeviewregional.com or call (985) 867-3800.
News Article | May 4, 2017
— Market Scenario: Integrated Cardiology devices are equipment in which surgeons use multiple devices to perform critical cardiac surgeries. The market for Integrated Cardiology device is expected to grow at a high CAGR. Key Players for Integrated Cardiology Device Market • Medtronic (US) • St. Jude Medical (US) • Boston Scientific Corporation (US) • Edwards Lifesciences Corporation (US) • Abbott Laboratories (US) • Johnson and Johnson (US) • Getinge (Sweden) • Terumo Corporation (Japan) • lepumedical (Bejing) • Acrostak (Switzerland) • Koninklijke Philips N.V. (Netherlands) • athenahealth, Inc. (U.S) Segments: on the basis of applications o Sudden Cardiac Arrest o Internal Monitoring o Cardiac Resynchronization Therapy o Cardiothoracic Surgery o Others On the basis of end users o Cardiac Catheterization Laboratories, o Hospitals o Clinics o Others On the basis of device types o Cardiology EMR Software o EHR o Fractional Flow Reserve (FFR) o Intracoronary Optical Coherence Tomography o Cloud Based Services o Others Study Objectives of Integrated Cardiology Devices Market: • To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the Global Integrated Cardiology Devices • To provide insights about factors affecting the market growth • To Analyze the Global Integrated Cardiology Devices Market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia, and Middle East & Africa • To provide country level analysis of the market with respect to the current market size and future prospective • To provide country level analysis of the market for segments by type, by end users and sub-segments. • To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Global Integrated Cardiology Devices Market Brief Table Of Content 1. Report Prologue 2. Introduction 2.1 Definition 2.2 Scope of the Study 2.2.1 Research Objective 2.2.2 Assumptions 2.2.3 Limitations 2.3 Market Structure 2.4. Market Segmentation 3. Research Methodology 3.1 Research Process 3.2 Primary Research 3.3 Secondary Research 3.4 Market Size Estimation 3.5 Forecast Model 4. Market Dynamics 4.1 Drivers 4.2 Restraints 4.3 Opportunities 4.4 Mega Trends 4.5 Macroeconomic Indicators 5. Market Factor Analysis 5.1 Value Chain Analysis 5.2 Porters Five Forces 5.3 Demand & supply: gap analysis 5.4 Pricing Analysis 5.5 Investment Opportunity Analysis 5.6 Merger and Acquisition Landscape 5.7 UP-Coming trends in IOT market 5.7.1 Market trends 5.7.2 Technological trends 5.7.3 Insurance & Regulations 5.7.4 Others Continue……. This research report has provides the insights, on various levels of analyses such industry analysis, market share analysis leading market players and their profiles. This report also helps in studying the target segments by providing views on emerging & high-growth segments and market conclusion. Together the market data comprise and discuss with the basic assessments on the competitive scenarios & strategies, of the Global Integrated Cardiology Devices Market, including the high-growth regions, countries and their political, economic and technological environments. Furthermore the project report also provides the views over the historical market values as well as, pricing and cost analysis of the same. Related Report Global Autism disorder and Treatment Information, by types (Autistic Disorder, Asperger Syndrome, Pervasive Developmental) by therapy treatment (neurofeedback, auditory integration training, chelation therapy, hyperbaric oxygen therapy, facilitated communication) by drug type (SSRIs, Anti-convulsants, Stimulants – Ritalin, Anti-psychotic, Risperidone) - Forecast to 2022 https://www.marketresearchfuture.com/reports/autism-disorder-treatment-market-1605 About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. For more information, please visit https://www.marketresearchfuture.com/reports/integrated-cardiology-devices-market
News Article | May 18, 2017
Patients at intermediate risk for surgery have lower stroke risk with TAVI than surgery TAVI is increasingly being used to treat patients at intermediate risk for surgical mortality who require aortic valve replacement. However, patients undergoing valve replacement face increased risk of death and long-term morbidity due to periprocedural stroke after either transcatheter or surgical valve replacement procedures. "As TAVI moves into lower-risk patients, it's important to understand the relative risk for neurological complications following surgical aortic value replacement and TAVI," explained the lead author of the SURTAVI trial, Pieter Kappetein, Professor in Cardiothoracic Surgery at Erasmus Medical Center, Rotterdam, the Netherlands. The trial randomised 1,660 patients with severe, symptomatic aortic stenosis and at intermediate surgical risk to aortic valve replacement with TAVI or surgery. A neurologist or stroke specialist evaluated any patient who had a suspected neurological event after their procedure. Results showed that the incidence of early stroke at 30 days was significantly lower in patients undergoing TAVI (3.3%) than in those having surgical aortic valve replacement (5.4%, p=0.031). Stroke incidence remained lower at two years with TAVI compared to surgery (6.3% vs. 8.0%, p=0.143). One-year mortality was similar for TAVI and surgery patients with stroke or with encephalopathy at 30 days. "Surgical aortic valve replacement carries a higher risk in intermediate-risk patients and TAVI might be the preferred treatment in patients with aortic stenosis," suggested Kappetein. He said, "This is the first time that there has been shown to be a lower stroke rate with TAVI compared to surgery," adding that the findings will change practice. Further results showed that quality of life, based on the SF-36 physical summary, was lower at 30 days for all patients with early stroke compared to those not having a stroke. Quality of life improved more quickly in TAVI patients with stroke but was similar by six months regardless of procedure type. EuroPCR 2017 session: Thursday 18 May 09:45-10:45, Hot Line/Late-breaking Trials, Coronary interventions, interventions for valvular disease, CTO, STEMI, Stents and scaffolds, TAVI; Main Arena For any press-related inquiries, please contact: Press registration for EuroPCR is open to accredited journalists, free of charge. Journalists must hold a valid press card and/or provide a letter of assignment from a recognised publication. To register as press go to https:/ EuroPCR press releases can be found at https:/ Abstracts are available online at https:/ EuroPCR, the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions (EAPCI), a registered branch of the European Society of Cardiology, is the world-leading course in interventional cardiovascular medicine. PCR has established a distinctive format for educational activities in the field of cardiovascular interventions. Beyond its flagship course in Paris that gathers more than 11,500 participants every year, PCR organises annual courses in Singapore, London UK, Dubai EAU, Johannesburg RSA, Milan Italy, Chengdu China and Tokyo Japan. For further information on EuroPCR, PCR London Valves, PCR Peripheral, PCR-CIT China Chengdu Valves, GulfPCR-GIM, AsiaPCR, AfricaPCR, PCR Tokyo Valves, and all PCR activities, please contact: Célia Vilà: firstname.lastname@example.org. For more information, please visit: https:/ and follow us on Twitter https:/ using the hashtag #EuroPCR
News Article | February 16, 2017
Global Surgical Robots Market Forecast to 2024 New report by Data Bridge Market Research Global Surgical Robots Market, by Product (Robotic Systems, Instruments and Accessories, Service), by Brands (Da Vinci Surgical System, Cyberknife, Renaissance, Flex, Artas, Rosa and Others), by Application (General Surgery, Urological, Gynaecological, Gastrointestinal, Radical Prostatectomy, Cardiothoracic Surgery, Colorectal Surgery, Radiotherapy and Others), by Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2024. Dallas, TX, February 16, 2017 --( The global surgical robots market is segmented on the basis of product, brands, application and by geography. On the basis of product the surgical robots market is segmented into systems, instruments and accessories and service. On the basis of the brands the surgical robots market is segmented into Da Vinci Surgical system, Renaissance, Flex, Cyberknife, Artas, Rosa and others. Based on application the surgical robots market is segmented into general surgery, urological, gynecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, Colon and rectal surgery and others. Request for sample pages: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/ Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. Read more: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/ The key players operating in this market are Intuitive Surgical, Inc., Verb Surgical Inc., Auris Surgical Robots, MedRobots Corporation, Restoration Robots, Inc., Virtual Incision Corporation, Think Surgical, Inc., Medtech Global, TransEnterix, Titan Medical Inc, Stryker, Accuray Inc., MAZOR Robots, Hansen Medical, Capsa Healthcare, LLC, Aesynt Inc, iRobot Corporation, ReWalk Robots, and Hocoma AG among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, February 16, 2017 --( PR.com )-- Global Surgical Robots market is expected to reach USD 14.5 billion by 2024 from USD 5.2 billion in 2016, at a CAGR of 13.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The global surgical robots market is segmented on the basis of product, brands, application and by geography.On the basis of product the surgical robots market is segmented into systems, instruments and accessories and service.On the basis of the brands the surgical robots market is segmented into Da Vinci Surgical system, Renaissance, Flex, Cyberknife, Artas, Rosa and others.Based on application the surgical robots market is segmented into general surgery, urological, gynecological, gastrointestinal, radiotherapy, radical prostatectomy, cardiothoracic surgery, Colon and rectal surgery and others.Request for sample pages: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.Read more: https://databridgemarketresearch.com/reports/surgical-robots-market-industry-trends-forecast-2024/The key players operating in this market are Intuitive Surgical, Inc., Verb Surgical Inc., Auris Surgical Robots, MedRobots Corporation, Restoration Robots, Inc., Virtual Incision Corporation, Think Surgical, Inc., Medtech Global, TransEnterix, Titan Medical Inc, Stryker, Accuray Inc., MAZOR Robots, Hansen Medical, Capsa Healthcare, LLC, Aesynt Inc, iRobot Corporation, ReWalk Robots, and Hocoma AG among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
News Article | December 16, 2016
The International Association of HealthCare Professionals is pleased to welcome Stephen Andrew Chung, MD, Anesthesiologist, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. Dr. Chung is a highly trained and qualified anesthesiologist with a vast expertise in all facets of his work. Dr. Chung has been in practice for more than 27 years and is currently serving patients at Valley Anesthesiology and Pain Consultants in Phoenix, Arizona. The center is one of the nation’s premier providers of anesthesia and pain management services, ensuring that their patients receive exceptional perioperative anesthesia care. Furthermore, Dr. Chung is affiliated with Scottsdale Healthcare and Banner Healthcare Network. Dr. Chung’s career in medicine began in 1987 when he graduated with his Medical Degree from the University of Calgary Faculty of Medicine. Following his graduation, Dr. Chung subsequently completed his internship at North York General Hospital, followed by his Cardiothoracic Surgery fellowship at the University of Toronto. Dr. Chung holds board certification in Anesthesiology, and keeps up to date with the latest advances and developments in his field through his professional membership with the American Society of Anesthesiologists, the Arizona Society of Anesthesiologists, and the Canadian Medical Association. He attributes his success to his good training, being flexible, and staying on top of the changes in medicine. When he is not assisting patients, Dr. Chung enjoys skiing, running, cooking, and watching college football. Learn more about Dr. Chung by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit:http://www.findatopdoc.com
News Article | October 29, 2016
Sonoma Magazine’s Top Doctor survey was submitted to Sonoma County doctors who were then asked which medical specialist they would most often recommend to a loved one, and 327 professionals emerged as top docs in 50 categories of medicine. Among physician peers Dr. Babajanian, Dr. Coleman, Dr. Dunlap and Dr. Korver ranked at the top for cardiology specialists, supporting what the many patients who routinely benefit from the expertise and outstanding cardiovascular services provided by these exemplary physicians already know. The NCMA Cardiovascular Services including Dr. Babajanian, Dr. Coleman, Dr. Dunlap and Dr. Korver is comprised of highly skilled physicians, specialists, nurses and other healthcare professionals dedicated to providing patients’ health care needs. Since 1975, the group has focused on sub-specialization within cardiovascular health to provide services by the most highly trained and experienced physicians and staff. Dr. Masis Babajanian is a fellowship trained cardiologist specializing in Cardiovascular Disease, Internal Medicine, Invasive Cardiology, Nuclear Cardiology and Pacemaker Implants. He received his medical degree from Stanford University School of Medicine and received his fellowship in cardiology from Tulane University School of Medicine, Department of Internal Medicine. Dr. Patrick Coleman is a board certified cardiologist with fellowship training in nuclear and interventional cardiology. He serves as the Medical Director of the Cardiac Catheterization Laboratories for both SRMH and Sutter Santa Rosa, as well as the Director of the Cardiology Section at NCMA. In addition to practicing cardiology at NCMA’s Santa Rosa and Ukiah offices, Dr. Coleman regularly gives lectures to the general public and health providers about maintaining and improving heart health and emergency response. Dr. Thomas Dunlap is a fellowship trained cardiologist specializing in Cardiovascular Disease, Peripheral Vascular, Endovascular Medicine, Interventional Cardiology and Pacemaker Implants. He is the Regional Director of Cardiac and Vascular Services at Santa Rosa Memorial Hospital and Director of the Cardiology Division of NCMA, and Chairman of the Endovascular Committee of Sutter Medical Center of Santa Rosa. He is published in numerous medical journals on cardiovascular health. Dr. Keith Korver is a fellowship trained Cardiothoracic Surgeon from UCSF School of Medicine as well as Pediatric Cardiac Surgery and Cardiac Transplant Surgery. He specializes in general and Cardiothoracic Surgery. NCMA Cardiology is comprised of a team of cardiologists and one cardiothoracic and vascular surgeon —all board-certified in their fields. NCMA’s HeartWorks Cardiac Rehabilitation Center provides each patient with a personal diet and exercise plan supervised by a team of physicians, nurses, and cardiac exercise specialists. In accordance with its practice of providing comprehensive cardiovascular health care, NCMA offers comprehensive care in areas including; NCMA’s services offers cardiac care in three counties, with 11 offices, located in Santa Rosa, Petaluma, Sonoma, Healdsburg, Fort Bragg, Mendocino, Gualala, Ukiah, and Lakeport. To learn more about NCMA Cardiology visit http://www.ncmahealth.com.
News Article | November 23, 2016
The International Association of HealthCare Professionals is pleased to welcome Zain Khalpey, MD, PhD, FACS, FETC, cardiothoracic surgeon, to their prestigious organization with his upcoming publication in The Leading Physicians of the World. He is a highly-trained and qualified cardiothoracic surgeon with expertise in all facets of his work. Dr. Zain Khalpey has been practicing for more than 18 years and is currently working at Arizona University Medical Center in Tucson, Arizona. He is also affiliated to Banner – University Medical Center. Dr. Zain Khalpey obtained his Doctor of Medicine degree at Guy’s, King’s & St. Thomas School of Medicine at the University of London in England in 1998. After moving to the United States, Dr. Khalpey completed a cardiac surgery internship at Brigham and Women’s Hospital prior to a residency was completed at Columbia University. Dr. Khalpey is certified by the American Board of Thoracic Surgery – Cardiac Surgery, and by the European Board of Cardiothoracic Surgery. He is internationally renowned as an expert in pediatric and adult heart transplantation, and remains a member of the American Association for Thoracic Surgery, the Society of Thoracic Surgeons, and the American Academy and Board of Regenerative Medicine. Dr. Khalpey has also earned the coveted title of Fellow of the American College of Surgeons, and he says that his success is due to his persistence and his passion for knowledge. Learn more about Dr. Khalpey by reading his upcoming publication in The Leading Physicians of the World. FindaTopDoc.com is a hub for all things medicine, featuring detailed descriptions of medical professionals across all areas of expertise, and information on thousands of healthcare topics. Each month, millions of patients use FindaTopDoc to find a doctor nearby and instantly book an appointment online or create a review. FindaTopDoc.com features each doctor’s full professional biography highlighting their achievements, experience, patient reviews and areas of expertise. A leading provider of valuable health information that helps empower patient and doctor alike, FindaTopDoc enables readers to live a happier and healthier life. For more information about FindaTopDoc, visit: http://www.findatopdoc.com
News Article | November 7, 2016
This report studies Global Minimally Invasive Surgical Instruments Market 2016, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Medtronic PLC Aesculap, Inc Stryker Corporation Smith & Nephew PLC Ethicon Inc Abbott Laboratories, Inc Applied Medicals Conmed Corporation Zimmer Holdings, Inc KLS Martin GmbH B. Braun By types, the market can be split into Handheld Instruments Guiding Device Inflation Systems Auxiliary Instruments Cutter Instruments By Application, the market can be split into Cardiothoracic Surgery Vascular Surgery Cosmetic/Bariatric Surgery Gastrointestinal Surgery Gynecological Surgery Urological Surgery Orthopedic Surgery Others By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Minimally Invasive Surgical Instruments Market Professional Survey Report 2016 1 Industry Overview of Minimally Invasive Surgical Instruments 1.1 Definition and Specifications of Minimally Invasive Surgical Instruments 1.1.1 Definition of Minimally Invasive Surgical Instruments 1.1.2 Specifications of Minimally Invasive Surgical Instruments 1.2 Classification of Minimally Invasive Surgical Instruments 1.2.1 Handheld Instruments 1.2.2 Guiding Device 1.2.3 Inflation Systems 1.2.4 Auxiliary Instruments 1.2.5 Cutter Instruments 1.3 Applications of Minimally Invasive Surgical Instruments 1.3.1 Cardiothoracic Surgery 1.3.2 Vascular Surgery 1.3.3 Cosmetic/Bariatric Surgery 1.3.4 Gastrointestinal Surgery 1.3.5 Gynecological Surgery 1.3.6 Urological Surgery 1.3.7 Orthopedic Surgery 1.3.8 Others 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 8 Major Manufacturers Analysis of Minimally Invasive Surgical Instruments 8.1 Medtronic PLC 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 184.108.40.206 Type I 220.127.116.11 Type II 18.104.22.168 Type III 8.1.3 Medtronic PLC 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Medtronic PLC 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.2 Aesculap, Inc 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 22.214.171.124 Type I 126.96.36.199 Type II 188.8.131.52 Type III 8.2.3 Aesculap, Inc 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Aesculap, Inc 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.3 Stryker Corporation 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 184.108.40.206 Type I 220.127.116.11 Type II 18.104.22.168 Type III 8.3.3 Stryker Corporation 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Stryker Corporation 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.4 Smith & Nephew PLC 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 22.214.171.124 Type I 126.96.36.199 Type II 188.8.131.52 Type III 8.4.3 Smith & Nephew PLC 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Smith & Nephew PLC 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.5 Ethicon Inc 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 184.108.40.206 Type I 220.127.116.11 Type II 18.104.22.168 Type III 8.5.3 Ethicon Inc 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Ethicon Inc 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.6 Abbott Laboratories, Inc 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 22.214.171.124 Type I 126.96.36.199 Type II 188.8.131.52 Type III 8.6.3 Abbott Laboratories, Inc 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Abbott Laboratories, Inc 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.7 Applied Medicals 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 184.108.40.206 Type I 220.127.116.11 Type II 18.104.22.168 Type III 8.7.3 Applied Medicals 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Applied Medicals 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.8 Conmed Corporation 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 22.214.171.124 Type I 126.96.36.199 Type II 188.8.131.52 Type III 8.8.3 Conmed Corporation 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Conmed Corporation 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.9 Zimmer Holdings, Inc 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 184.108.40.206 Type I 220.127.116.11 Type II 18.104.22.168 Type III 8.9.3 Zimmer Holdings, Inc 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Zimmer Holdings, Inc 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.10 KLS Martin GmbH 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 22.214.171.124 Type I 126.96.36.199 Type II 188.8.131.52 Type III 8.10.3 KLS Martin GmbH 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 KLS Martin GmbH 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis 8.11 B. Braun 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 184.108.40.206 Type I 220.127.116.11 Type II 18.104.22.168 Type III 8.11.3 B. Braun 2015 Minimally Invasive Surgical Instruments Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.11.4 B. Braun 2015 Minimally Invasive Surgical Instruments Business Region Distribution Analysis Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.
News Article | November 22, 2016
According to Stratistics MRC, the Global Minimally Invasive Surgical Instruments market is expected to grow from $9.34 billion in 2015 to reach $21.23 billion by 2022 with a CAGR of 12.4%. Better performance of minimally invasive surgeries as compared to traditional open surgeries is the main driving factor fueling the market growth. Moreover, rising chronic disorders as well surgeries and innovative technological improvements are the factors boosting the market growth. On the other hand, lack of skilled surgeons to adopt new technologies and unstable regulations in the medical industries are restricting the market growth. Access the complete report at: http://www.strategymrc.com/report/minimally-invasive-surgical-instruments-market The orthopedic surgery segment leads the market globally with the biggest market share and is expected to grow with a high CAGR during the forecast period. The growth of this segment is attributed to increasing geriatric population coupled with bone disorders and rising spine injuries. Among all product types, the handheld instruments segment dominates the global market. This is due to vast usage of the handheld instrument in most of all minimally invasive surgeries. North America is leading the global market with a higher CAGR. Asia Pacific is projected to grow at a faster pace during the forecast period. Increasing government spending, growing numerous surgeries, increasing adoption of latest surgical instruments are the factors contributing to the North America market growth. Some of the key players in global minimally invasive surgical instruments market include Davol, Inc., Conmed Corporation, Aesculap, Inc. (Subsidiary of B. Braun Melsungen AG), Aesculap, Inc., Ethicon Endo-Surgery, Inc., Encision, Inc., Acmi Circon, Abbott Laboratories , Ethicon, Inc. (Subsidiary of Johnson & Johnson), Karl Storz Endoscopy-American, Inc., Smith & Nephew PLC, Olympus Corp. of America, Microline Surgicals, Inc. (Subsidiary of Hoya Corporation), Zimmer Biomet Holdings, Inc., Stryker Corporation, and Medtronic PLC. Request for a sample at: http://www.strategymrc.com/report/minimally-invasive-surgical-instruments-market Products Covered: • Cutter Instruments o Rasps o Trocars o Other Cutter Instruments • Inflation Systems o Balloon Inflation Devices o Balloons o Other Inflation Systems • Auxiliary Instruments o Cannulas o Clamps o Closure Devices o Staplers • Handheld Instruments o Dilators o Forceps and Spatulas o Graspers o Retractors o Stents o Sutures o Visualizing scopes o Other Products • Electrosurgical Instruments o Electrocautery Devices o Electrosurgical Generators o Electrosurgical Instruments • Guiding Devices o Guidewires o Guiding Catheters End Users Covered: • Academic and Research Institutes • Government Hospitals • Private Hospitals and Surgical Clinics Applications Covered: • Gastrointestinal surgery • Cosmetic/Bariatric Surgery • Cardiothoracic Surgery • Vascular Surgery • Urological Surgery • Orthopedic Surgery • Gynecological Surgery • Other Applications o ENT/Respiratory Surgery o Neurological Surgery o Dental Surgery o Pediatric Surgery Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements